Back to Search
Start Over
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
- Source :
-
Cancer communications (London, England) [Cancer Commun (Lond)] 2024 Aug; Vol. 44 (8), pp. 884-888. Date of Electronic Publication: 2024 Jul 06. - Publication Year :
- 2024
- Subjects :
- Humans
Animals
Receptor, Transforming Growth Factor-beta Type I antagonists & inhibitors
Mice
Bone Neoplasms drug therapy
Bone Neoplasms immunology
Bone Neoplasms pathology
Cell Line, Tumor
Xenograft Model Antitumor Assays
Administration, Oral
Osteosarcoma drug therapy
Osteosarcoma immunology
Cell Proliferation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2523-3548
- Volume :
- 44
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Cancer communications (London, England)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38970391
- Full Text :
- https://doi.org/10.1002/cac2.12589